Confirm presence of Rickettsia typhi. Requires comparison of acute- to convalescent-phase serology.
Semi-Quantitative Indirect Fluorescent Antibody
New York DOH Approval Status
Serum Separator Tube (SST).
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Contaminated, hemolyzed, or severely lipemic specimens.
Mark specimens plainly as "acute" or "convalescent."
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|0050381||Rickettsia typhi (Typhus Fever) Antibody, IgG by IFA||
|0050383||Rickettsia typhi (Typhus Fever) Antibody, IgM by IFA||
Antibody reactivity to Rickettsia typhi antigen should be considered group-reactive for the Typhus Fever group, which includes Rickettsia prowazekii.
Seroconversion between acute and convalescent sera is considered strong evidence of recent infection. The best evidence for infection is a significant change (fourfold difference in titer) on two appropriately timed specimens, where both tests are done in the same laboratory at the same time. Acute-phase specimens are collected during the first week of illness and convalescent-phase samples are generally obtained 2-4 weeks after resolution of illness. Ideally, these samples should be tested simultaneously at the same facility. If the sample submitted was collected during the acute phase of illness, submit a marked convalescent sample within 25 days for paired testing.
|Component Test Code*||Component Chart Name||LOINC|
|0050381||Typhus Fever Antibody, IgG||5324-9|
|0050383||Typhus Fever Antibody, IgM||5325-6|
- Murine Typhus Antibodies
- R. typhi antibodies
- Typhus Fever Group Antibody, IgG and IgM, Serum